Dyadic International Inc (DYAI) — SEC Filings
Dyadic International Inc (DYAI) — 28 SEC filings. Latest: 8-K (Dec 29, 2025). Includes 16 8-K, 6 10-Q, 2 DEF 14A.
View Dyadic International Inc on SEC EDGAR
Overview
Dyadic International Inc (DYAI) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 29, 2025: Dyadic International, Inc. filed an 8-K on December 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event reported on December 19, 2025. The company, incorporated in Delaware, is involved in Biological Products.
Sentiment Summary
Across 28 filings, the sentiment breakdown is: 5 bearish, 22 neutral, 1 mixed. The dominant filing sentiment for Dyadic International Inc is neutral.
Filing Type Overview
Dyadic International Inc (DYAI) has filed 16 8-K, 6 10-Q, 2 DEF 14A, 2 10-K, 2 SC 13G/A with the SEC between Feb 2024 to Dec 2025.
Filings by Year
Recent SEC Filings (28)
Risk Profile
Risk Assessment: Of DYAI's 25 recent filings, 5 were flagged as high-risk, 14 as medium-risk, and 6 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $2,524,819 |
| Net Income | -$5,797,365 |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $5,834,510 |
| Operating Margin | N/A |
| Total Assets | $11,672,757 |
| Total Debt | N/A |
Key Executives
- Mark Emalfarb
- Mr. Thomas Emalfarb
- Mr. Mark A. Emalfarb
- Joseph Hazelton
- Ping Wang Rawson
- Jack Kaye
Industry Context
Dyadic International operates in the biotechnology sector, focusing on protein production. The industry is characterized by high R&D costs, long development cycles, and significant regulatory hurdles. The company's strategic shift towards non-therapeutic proteins places it in a segment that may have different market dynamics and competitive pressures compared to traditional biopharmaceuticals.
Top Tags
material-agreement (7) · filing (5) · financials (4) · delisting (3) · disclosure (3) · corporate-governance (3) · 10-Q (3) · Dyadic International (3) · listing-standards (2) · regulatory (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net loss for nine months ended Sep 30, 2025 | $5,797,365 | Increased from $4,258,279 in 2024, indicating worsening profitability. |
| Total revenue for nine months ended Sep 30, 2025 | $2,524,819 | Decreased from $2,678,013 in 2024, primarily due to lower license revenue. |
| Grant revenue for nine months ended Sep 30, 2025 | $1,528,224 | Significant increase from $0 in 2024, partially offsetting other revenue declines. |
| Net proceeds from public offering | $4,940,696 | Received in Q3 2025, boosting financing activities. |
| Convertible notes purchased by MAE Trust | $1,000,000 | Related party financing on September 15, 2025. |
| Cash and cash equivalents as of Sep 30, 2025 | $5,834,510 | Decreased from $6,506,750 at December 31, 2024. |
| Total assets as of Sep 30, 2025 | $11,672,757 | Increased from $9,930,275 at December 31, 2024. |
| Common shares outstanding as of Nov 11, 2025 | 36,187,798 | Increased from 29,835,799 as of December 31, 2024. |
| SEC File Number | 001-32513 | Identifies the company's filings with the SEC. |
| EIN | 45-0486747 | Employer Identification Number for tax purposes. |
| Net loss for Q2 2025 | $1,793,774 | Improved from $2,045,223 in Q2 2024 |
| Net loss for H1 2025 | $3,821,353 | Improved from $4,054,819 in H1 2024 |
| Total revenue for Q2 2025 | $966,630 | Increased from $385,896 in Q2 2024 |
| Grant revenue for Q2 2025 | $503,181 | New revenue stream, zero in Q2 2024 |
| License and milestone revenue for Q2 2025 | $250,000 | New revenue stream, zero in Q2 2024 |
Frequently Asked Questions
What are the latest SEC filings for Dyadic International Inc (DYAI)?
Dyadic International Inc has 28 recent SEC filings from Feb 2024 to Dec 2025, including 16 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of DYAI filings?
Across 28 filings, the sentiment breakdown is: 5 bearish, 22 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Dyadic International Inc SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Dyadic International Inc (DYAI) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Dyadic International Inc?
Key financial highlights from Dyadic International Inc's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for DYAI?
The investment thesis for DYAI includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Dyadic International Inc?
Key executives identified across Dyadic International Inc's filings include Mark Emalfarb, Mr. Thomas Emalfarb, Mr. Mark A. Emalfarb, Joseph Hazelton, Ping Wang Rawson and 1 others.
What are the main risk factors for Dyadic International Inc stock?
Of DYAI's 25 assessed filings, 5 were flagged high-risk, 14 medium-risk, and 6 low-risk.
What are recent predictions and forward guidance from Dyadic International Inc?
Forward guidance and predictions for Dyadic International Inc are extracted from SEC filings as they are enriched.